SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Transkaryotic(tktx)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: trevor john wilkinson who started this subject4/22/2002 9:12:41 AM
From: IRWIN JAMES FRANKEL  Read Replies (1) of 122
 
08:59 ET TKTX Transkaryotic named Bottom Line Action Idea at Cowen (40.88)
SG Cowen names TKTX their "Bottom Line Action Idea of the Week" as the co will feature Replagal at the Lysosomal Disease Symposium on April 26-27; expects co's presentations to highlight the competitive advantages of Replagal over GENZ's Fabrazyme and therefore to provide a near-term trigger as TKTX approaches a period of strong news flow.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News